Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans... see more

TSXV:NU.H - Post Discussion

NeutriSci International Inc > A little profit taking
View:
Post by geodcan on Jan 20, 2021 2:15pm

A little profit taking

but don't underestimate the driving forces of the stock market that sometimes succumb to irrational exuberance.  Our recent spike up in volume and price may have been a group of investors in Frankfurt motivated by an overzealous promoter and/or a house committment to stir up investor interest.   Any stock that shoots up like this did is subject to profit taking.  I am willing to wait for real potential based on real numbers and have higher multiple expectations than the penny traders and day flippers.  We have a new line of products that are unique and we have just made sales to Japan.  It is now up to Japanese consumers to decide on our faith but my due diligence suggests that consumers are ready and waiting for this experience.  I can justify my conviction based on Canopy's Tweed cannabinoid infused beverages that are selling increasing volumes of beverages that I personally find lacking in taste and effect.  Our blueberry magic is incorporated into these Neutrisci formulations and indications are that consumers are looking for new cannabinoid infused products for health and enjoyment.  I do believe that the Tabletz are health and energy suggestive and in Japan we are cleared for takeoff.  We are now waiting for the jury to report back and we also have indications that Cryopharm manufactured products are making there way to consumers in California which is huge considering the politickin' that has been strangling value added manufacturers at every level of government.  I still think there is room for some irrational exuberance in the pricing for our shares for all the promise this style of products is showing and the high margins that should make their way to the bottom line and to patient shareholders.  glta and dyodd
Comment by geodcan on Jan 20, 2021 2:22pm
fate not faith!
Comment by Edcando on Jan 20, 2021 2:27pm
Lol a group of investors in Germany did not trade over 25 million shares in Canada hahaha. A retrace is healthy. There's no need for any explanation . Having said that if one really needs it, sell pressure to convert over 10 million warrants and take profits while keeping share count the same is a far more realistic one than the one posited here. Regardless this jump was on fundamentals and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities